Prazosin for the Treatment of Alcohol Use Disorders

Am J Psychiatry. 2018 Dec 1;175(12):1159-1160. doi: 10.1176/appi.ajp.2018.18091022.

Author

Affiliation

¹ From the Yale Stress Center and the Departments of Psychiatry and Neuroscience, Yale University School of Medicine, New Haven, Conn.

PMID: 30501414
DOI: 10.1176/appi.ajp.2018.18091022

No abstract available

Keywords: Alcohol Abuse; Clinical Drug Studies; Noradrenergic; Prazosin.

Publication types

Editorial
Comment

MeSH terms

Alcohol Drinking
Alcoholism*
Double-Blind Method
Humans
Prazosin*

Substances

Prazosin